Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "Head"

1642 News Found

Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec
Biotech | April 29, 2022

Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec

In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec


Lupin Diagnostics launches reference laboratory in Guwahati, Assam
Diagnostic Center | April 29, 2022

Lupin Diagnostics launches reference laboratory in Guwahati, Assam

It is expanding the diagnostics business footprint in North East India


Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance
Digitisation | April 28, 2022

Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance

When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room


Wipro GE Healthcare launches locally made CT system
Healthcare | April 28, 2022

Wipro GE Healthcare launches locally made CT system

Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme


Tembo BV team in India to assist UFlex-Asepto for U-shaped paper straw line
Packaging | April 27, 2022

Tembo BV team in India to assist UFlex-Asepto for U-shaped paper straw line

Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers


Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer
Biotech | April 27, 2022

Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer

Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers


Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study
Biotech | April 27, 2022

Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study

Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours


Syngene full-year revenue from operations up 19% to Rs. 2604 crore
News | April 27, 2022

Syngene full-year revenue from operations up 19% to Rs. 2604 crore

Revenue from operations up 15% to Rs. 758 crore in fourth quarter


Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation